Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]

Saved in:
Bibliographic Details
Main Authors: Tsuyoshi Hirata, MD, Yuji Uehara, MD, Taiki Hakozaki, MD, Takayuki Kobayashi, MD, Yuto Terashima, MD, Kageaki Watanabe, MD, Makiko Yomota, MD, PhD, Yukio Hosomi, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364324001310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594141039558656
author Tsuyoshi Hirata, MD
Yuji Uehara, MD
Taiki Hakozaki, MD
Takayuki Kobayashi, MD
Yuto Terashima, MD
Kageaki Watanabe, MD
Makiko Yomota, MD, PhD
Yukio Hosomi, MD, PhD
author_facet Tsuyoshi Hirata, MD
Yuji Uehara, MD
Taiki Hakozaki, MD
Takayuki Kobayashi, MD
Yuto Terashima, MD
Kageaki Watanabe, MD
Makiko Yomota, MD, PhD
Yukio Hosomi, MD, PhD
author_sort Tsuyoshi Hirata, MD
collection DOAJ
format Article
id doaj-art-61fbb0694c7c4c1b84ab6693720282c6
institution Kabale University
issn 2666-3643
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series JTO Clinical and Research Reports
spelling doaj-art-61fbb0694c7c4c1b84ab6693720282c62025-01-20T04:17:54ZengElsevierJTO Clinical and Research Reports2666-36432025-01-0161100761Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]Tsuyoshi Hirata, MD0Yuji Uehara, MD1Taiki Hakozaki, MD2Takayuki Kobayashi, MD3Yuto Terashima, MD4Kageaki Watanabe, MD5Makiko Yomota, MD, PhD6Yukio Hosomi, MD, PhD7Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanDepartment of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo, Japan; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan; Corresponding author: Yuji Uehara.Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, JapanDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japanhttp://www.sciencedirect.com/science/article/pii/S2666364324001310
spellingShingle Tsuyoshi Hirata, MD
Yuji Uehara, MD
Taiki Hakozaki, MD
Takayuki Kobayashi, MD
Yuto Terashima, MD
Kageaki Watanabe, MD
Makiko Yomota, MD, PhD
Yukio Hosomi, MD, PhD
Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
JTO Clinical and Research Reports
title Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
title_full Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
title_fullStr Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
title_full_unstemmed Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
title_short Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
title_sort corrigendum to brief report clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with locally advanced nsclc jto clinical and research reports volume 5 issue 4 2024 100659
url http://www.sciencedirect.com/science/article/pii/S2666364324001310
work_keys_str_mv AT tsuyoshihiratamd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT yujiueharamd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT taikihakozakimd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT takayukikobayashimd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT yutoterashimamd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT kageakiwatanabemd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT makikoyomotamdphd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659
AT yukiohosomimdphd corrigendumtobriefreportclinicaloutcomesbyinfusiontimingofimmunecheckpointinhibitorsinpatientswithlocallyadvancednsclcjtoclinicalandresearchreportsvolume5issue42024100659